The estimated Net Worth of Nicholas A Lopardo is at least $8.7 Million dollars as of 5 February 2019. Nicholas Lopardo owns over 1,600 units of Revvity stock worth over $4,569,519 and over the last 21 years Nicholas sold PKI stock worth over $4,129,553.
Nicholas has made over 19 trades of the Revvity stock since 2006, according to the Form 4 filled with the SEC. Most recently Nicholas sold 1,600 units of PKI stock worth $148,272 on 5 February 2019.
The largest trade Nicholas's ever made was selling 30,000 units of Revvity stock on 12 August 2015 worth over $1,485,600. On average, Nicholas trades about 5,477 units every 141 days since 2004. As of 5 February 2019 Nicholas still owns at least 39,635 units of Revvity stock.
You can see the complete history of Nicholas Lopardo stock trades at the bottom of the page.
Nicholas's mailing address filed with the SEC is 45 WILLIAM STREET, , WELLESLEY, MA, 02481.
Over the last 26 years, insiders at Revvity have traded over $204,298,889 worth of Revvity stock and bought 55,200 units worth $1,110,570 . The most active insiders traders include Alexis P Michas, Gregory L Summe, and Robert F Friel. On average, Revvity executives and independent directors trade stock every 25 days with the average trade being worth of $6,184,617. The most recent stock trade was executed by Andrew Okun on 13 April 2023, trading 2,435 units of PKI stock currently worth $332,402.
PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique solutions to serve the diagnostics, life sciences, food, and applied markets. IT strategically partners with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Its dedicated team of about 14,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $3.8 billion in 2020, serves customers in 190 countries, and is a component of the S&P 500 index.
Revvity executives and other stock owners filed with the SEC include: